News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Waltermire Robert E.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
4
| Waltermire Robert E. (Senior VP, Chief Pharma Dev.) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Sold 900 shares
@ $271.03, valued at
$243.9k
Sold 4,100 shares
@ $272.3, valued at
$1.1M
Sold 1,928 shares
@ $273.44, valued at
$527.2k
Sold 1,672 shares
@ $274.57, valued at
$459.1k
Sold 1,300 shares
@ $275.53, valued at
$358.2k
Sold 100 shares
@ $276.19, valued at
$27.6k
Exercised 5,000 options to buy
@ $87.92, valued at
$439.6k
Exercised 5,000 options to buy
@ $87.92, valued at
$439.6k
|
|
| 01/18/2023 |
4
| Waltermire Robert E. (Senior VP, Chief Pharma Dev.) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 5,667 shares
@ $0 |
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|